Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
- Therapeutic Areas
Our expertise in the industry
Amgen has announced to purchase 20.5% of the stake in Chinese-American drug company BeiGene.As per the deal signed, Amgen will develop and commercialize around two dozen of its on-market as w...
The present Hepatocellular Carcinoma market size is mainly dominated by the protein Kinase inhibitor i.e., Nexavar (Sorafenib) developed by Bayer is considered the first line of treatment. Followe...
EU recommends the use of Imbruvica for two new indicationsThe Janssen Pharmaceutical has received the approval for its drug Imbruvica (ibrutinib) from the European Commission (EC). Ibrutinib i...
Bexion Pharmaceuticals’ Early-Stage Cancer Drug, BXQ-350 Hailed as Game Changer For the Treatment of solid tumors and gliomasBexion Pharmaceuticals’ investigational cancer treatment, BXQ-350, i...
Sanofi pays €120M to buy into AstraZeneca RSV program Sanofi has paid €120 million ($126 million) upfront and committed to up to €495 million more for a stake in AstraZeneca’s experimental monoclon...
In advanced cancer patients, the most common site for the occurrence of metastasis is c...
Depression is a mental condition characterized by prolonged series of poor moods, loss ...
Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It ...
West syndrome is a rare form of neurological disorder, an age-related specific Epilepti...
Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
.png)
